<!-- min-version: 37 -->
<!--TODO: check when version 37 is released, since this was written before! -->
<!-- NOTE: this adds conversion model parameters, since these models were not
   - functioning properly in older OpenMalaria versions. -->
<!-- snippet: om:pharmacology -->
<!-- disclaimer: this may not work as intended -->
<!-- Data checked against unit test / LSTM script on 2016-06-23 -->
  <pharmacology>
    <!-- This is a library of drug parameters and treatment schedules
    parameterised for OpenMalaria. All drug parameters were provided by
    Katherine Kay (LSTM); schedules and dosage information has varying sources.
    
    This library can be copied into the relevant section of a scenario
    document. Unused drugs, schedules and dosages may (if desired) be deleted.
    
    Note: currently no variance of PK/PD parameters is included. Possibly it
    should be.
    -->
    <treatments>
        <!-- Note that most of these simply give a fixed dosage per person,
           - instead of modelling dose based on weight or age.
           - This can be done; see dosages examples below (which multiply
           - dose) and documentation on wiki). -->
      <schedule name="AL_full">
        <!-- Recommended Artemether-Lumefantrine dosing schedule.
           - Dose sizes are single tablets; the separate dosage table lists
           - the number of tablets recommended.
           - Source: WHO / Novartis product information -->
        <medicate drug="AR" hour="0" mg="20"/>
        <medicate drug="LF" hour="0" mg="120"/>
        <medicate drug="AR" hour="8" mg="20"/>
        <medicate drug="LF" hour="8" mg="120"/>
        <medicate drug="AR" hour="24" mg="20"/>
        <medicate drug="LF" hour="24" mg="120"/>
        <medicate drug="AR" hour="36" mg="20"/>
        <medicate drug="LF" hour="36" mg="120"/>
        <medicate drug="AR" hour="48" mg="20"/>
        <medicate drug="LF" hour="48" mg="120"/>
        <medicate drug="AR" hour="60" mg="20"/>
        <medicate drug="LF" hour="60" mg="120"/>
      </schedule>
      <schedule name="AL_bad_adherence">
        <medicate drug="AR" hour="0" mg="20"/>
        <medicate drug="LF" hour="0" mg="120"/>
      </schedule>
      <schedule name="AR">
        <!-- schedule as used by KK & IH -->
        <!-- dosage is 1.7mg/kg; assuming weight of 50kg gives 85mg -->
        <medicate drug="AR" hour="0" mg="85"/>
        <medicate drug="AR" hour="12" mg="85"/>
        <medicate drug="AR" hour="24" mg="85"/>
        <medicate drug="AR" hour="36" mg="85"/>
        <medicate drug="AR" hour="48" mg="85"/>
        <medicate drug="AR" hour="60" mg="85"/>
      </schedule>
      <schedule name="AS">
        <!-- schedule as used by KK & IH -->
        <!-- dosage is 4mg/kg; assuming weight of 50kg gives 200mg -->
        <medicate drug="AS" hour="0" mg="200"/>
        <medicate drug="AS" hour="24" mg="200"/>
        <medicate drug="AS" hour="48" mg="200"/>
      </schedule>
      <schedule name="LF">
        <!-- schedule as used by KK & IH -->
        <!-- dosage is 12mg/kg; assuming weight of 50kg gives 600mg -->
        <medicate drug="AR" hour="0" mg="600"/>
        <medicate drug="AR" hour="12" mg="600"/>
        <medicate drug="AR" hour="24" mg="600"/>
        <medicate drug="AR" hour="36" mg="600"/>
        <medicate drug="AR" hour="48" mg="600"/>
        <medicate drug="AR" hour="60" mg="600"/>
      </schedule>
      <schedule name="MQ">
        <!-- schedule as used by KK & IH -->
        <!-- dosage is 8.3mg/kg; assuming weight of 50kg gives 415mg -->
        <medicate drug="AS" hour="0" mg="415"/>
        <medicate drug="AS" hour="24" mg="415"/>
        <medicate drug="AS" hour="48" mg="415"/>
      </schedule>
      <schedule name="PPQ">
        <!-- schedule as used by KK & IH -->
        <!-- dosage is 18mg/kg; assuming weight of 50kg gives 900mg -->
        <medicate drug="AS" hour="0" mg="900"/>
        <medicate drug="AS" hour="24" mg="900"/>
        <medicate drug="AS" hour="48" mg="900"/>
      </schedule>
      <dosages name="AL_age">
        <!-- This dosing information was provided by Valerie Crowell; not sure of source -->
        <age lowerbound="0" dose_mult="1"/>
        <age lowerbound="3" dose_mult="2"/>
        <age lowerbound="9" dose_mult="3"/>
        <age lowerbound="15" dose_mult="4"/>
      </dosages>
      <dosages name="AL_mass">
        <!-- Source: WHO / Novartis product information -->
        <!-- Note: there is no recommended dose for <5kg, but WHO guidelines
          are to use (certain) ACTs anyway. -->
        <bodymass lowerbound="0" dose_mult="1"/>
        <bodymass lowerbound="15" dose_mult="2"/><!-- 2 tablets -->
        <bodymass lowerbound="25" dose_mult="3"/><!-- 3 tablets -->
        <bodymass lowerbound="35" dose_mult="4"/><!-- 4 tablets. -->
        <!-- Note: WHO points out there is a lack of evidence about dosing
          large adults, thus does not recommend higher doses. -->
      </dosages>
    </treatments>
    <drugs>
      <drug abbrev="AR"><!-- Artemether, conversion model -->
        <PD>
          <phenotype name="sensitive">
            <max_killing_rate>27.6</max_killing_rate>
            <IC50>0.0023</IC50>
            <slope>4</slope>
          </phenotype>
        </PD>
        <PK>
          <negligible_concentration>1e-17</negligible_concentration>
          <k mean="0"/>
          <m_exponent>0</m_exponent>
          <k_a mean="23.98"/>
          <vol_dist>46.6</vol_dist>
          <conversion>
            <metabolite>DHA_AR<metabolite/>
            <rate mean="11.98"/>
            <molRatio>0.9547587</molRatio>
          </conversion>
        </PK>
      </drug>
      <drug abbrev="DHA_AR"><!-- DHA derived from Artemether -->
        <PD>
          <phenotype name="sensitive">
            <max_killing_rate>27.6</max_killing_rate>
            <IC50>0.009</IC50>
            <slope>4</slope>
          </phenotype>
        </PD>
        <PK>
          <negligible_concentration>1e-17</negligible_concentration>
          <k mean="44.15"/>
          <m_exponent>0</m_exponent>
          <vol_dist>15</vol_dist>
        </PK>
      </drug>
      <drug abbrev="AR1"><!-- Artemether, one compartment model -->
        <PD>
          <phenotype name="sensitive">
            <max_killing_rate>27.6</max_killing_rate>
            <IC50>0.0023</IC50>
            <slope>4</slope>
          </phenotype>
        </PD>
        <PK>
          <negligible_concentration>1e-17</negligible_concentration>
          <k mean="3.96"/>
          <vol_dist>17.4</vol_dist>
        </PK>
      </drug>
      <drug abbrev="AS"><!-- Artesunate, conversion model -->
        <PD>
          <phenotype name="sensitive">
            <max_killing_rate>27.6</max_killing_rate>
            <IC50>0.0016</IC50>
            <slope>4</slope>
          </phenotype>
        </PD>
        <PK>
          <negligible_concentration>1e-45</negligible_concentration>
          <k mean="0"/>
          <m_exponent>0</m_exponent>
          <k_a mean="252"/>
          <vol_dist>7.1</vol_dist>
          <conversion>
            <metabolite>DHA_AS<metabolite/>
            <rate mean="30.96"/>
            <molRatio>0.741155</molRatio>
          </conversion>
        </PK>
      </drug>
      <drug abbrev="DHA_AS"><!-- DHA derived from Artesunate -->
        <PD>
          <phenotype name="sensitive">
            <max_killing_rate>27.6</max_killing_rate>
            <IC50>0.009</IC50>
            <slope>4</slope>
          </phenotype>
        </PD>
        <PK>
          <negligible_concentration>1e-35</negligible_concentration>
          <k mean="25.4"/>
          <m_exponent>0</m_exponent>
          <vol_dist>1.49</vol_dist>
        </PK>
      </drug>
      <drug abbrev="AS1"><!-- Artesunate, one compartment model -->
        <PD>
          <phenotype name="sensitive">
            <max_killing_rate>27.6</max_killing_rate>
            <IC50>0.0016</IC50>
            <slope>4</slope>
          </phenotype>
        </PD>
        <PK>
          <negligible_concentration>1e-17</negligible_concentration>
          <k mean="16.6"/>
          <m_exponent>0</m_exponent>
          <vol_dist>2.75</vol_dist>
        </PK>
      </drug>
      <drug abbrev="DHA"><!-- Dihydroartemisinin -->
        <PD>
          <phenotype name="sensitive">
            <max_killing_rate>27.6</max_killing_rate>
            <IC50>0.009</IC50>
            <slope>4</slope>
          </phenotype>
        </PD>
        <PK>
          <negligible_concentration>1e-17</negligible_concentration>
          <k mean="19.8"/>
          <m_exponent>0</m_exponent>
          <vol_dist>1.49</vol_dist>
        </PK>
      </drug>
      <drug abbrev="CQ"><!-- Chloroquine -->
        <PD>
          <phenotype name="sensitive">
            <max_killing_rate>3.45</max_killing_rate>
            <IC50>0.02</IC50>
            <slope>1.6</slope>
          </phenotype>
        </PD>
        <PK>
          <negligible_concentration>0.00036</negligible_concentration>
          <half_life>30.006</half_life>
          <vol_dist>300</vol_dist>
        </PK>
      </drug>
      <drug abbrev="LF"><!-- Lumefantrine -->
        <PD>
          <phenotype name="sensitive">
            <max_killing_rate>3.45</max_killing_rate>
            <IC50>0.032</IC50>
            <slope>4</slope>
          </phenotype>
        </PD>
        <PK>
          <negligible_concentration>0.00032</negligible_concentration>
          <k mean="0.16"/>
          <m_exponent>0</m_exponent>
          <vol_dist>21</vol_dist>
        </PK>
      </drug>
      <drug abbrev="MQ"><!-- Mefloquine -->
        <PD>
          <phenotype name="sensitive">
            <max_killing_rate>3.45</max_killing_rate>
            <IC50>0.027</IC50>
            <slope>5</slope>
          </phenotype>
        </PD>
        <PK>
          <negligible_concentration>0.005</negligible_concentration>
          <half_life>13.078</half_life>
          <vol_dist>20.8</vol_dist>
        </PK>
      </drug>
      <drug abbrev="PPQ1"><!-- Piperaquine 1-compartment (poor model) -->
        <PD>
          <phenotype name="sensitive">
            <max_killing_rate>3.45</max_killing_rate>
            <IC50>0.020831339</IC50>
            <slope>6</slope>
          </phenotype>
        </PD>
        <PK>
          <negligible_concentration>0.005</negligible_concentration>
          <k mean="0.03"/>
          <m_exponent>0</m_exponent>
          <vol_dist>150</vol_dist>
        </PK>
      </drug>
      <drug abbrev="PPQ"><!-- Piperaquine 2-compartment Hodel 2013 (best data and likely best model) -->
        <PD>
          <phenotype name="sensitive">
            <max_killing_rate>3.45</max_killing_rate>
            <IC50>0.020831339</IC50>
            <slope>6</slope>
          </phenotype>
        </PD>
        <PK>
          <negligible_concentration>0.005</negligible_concentration>
          <k mean="0.6242774566473989" sigma="0"/>
          <m_exponent>0.25</m_exponent>
          <vol_dist>173</vol_dist>
          <k_a mean="11.16"/>
          <compartment2>
            <a12 mean="8.46242774566474" sigma="0"/>
            <a21 mean="3.3058064516129035" sigma="0"/>
          </compartment2>
        </PK>
      </drug>
      <drug abbrev="PPQ3"><!-- Piperaquine 3-compartment Tarning 2012 AAC -->
        <PD>
          <phenotype name="sensitive">
            <max_killing_rate>3.45</max_killing_rate>
            <IC50>0.020831339</IC50>
            <slope>6</slope>
          </phenotype>
        </PD>
        <PK>
          <negligible_concentration>0.005</negligible_concentration>
          <k mean="16.314788273615637" sigma="0"/>
          <m_exponent>1</m_exponent>
          <vol_dist>57.5625</vol_dist>
          <compartment2>
            <a12 mean="89.01628664495114" sigma="0"/>
            <a21 mean="55.394594594594594" sigma="0"/>
          </compartment2>
          <compartment3>
            <a13 mean="43.36156351791531" sigma="0"/>
            <a31 mean="3.8155414012738853" sigma="0"/>
          </compartment3>
        </PK>
      </drug>
    </drugs>
  </pharmacology>
